Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Cramer, Hagen
25  Ergebnisse:
Personensuche X
?
1

CMC and regulatory aspects of oligonucleotide therapeutics:

, In: RNA Therapeutics,
Rupp, Thomas M. ; Cramer, Hagen - p. 263-320 , 2022
Link: https://doi.org/10.1016/..
 
?
2

Contributors:

, In: RNA Therapeutics,
Alameh, Mohamad-Gabriel ; Alcantara, Marice ; Alluin, Jessica... - p. xiii-xvi , 2022
Link: https://doi.org/10.1016/..
 
?
3

2-5A Ligands—A New Concept for the Treatment of Prostate Ca..:

Cramer, Hagen ; Okicki, James R. ; Rho, Taikyun...
Nucleosides, Nucleotides and Nucleic Acids.  26 (2007)  10-12 - p. 1471-1477 , 2007
Link: https://doi.org/10.1080/..
 
?
4

TARGETED THERAPY OF RESPIRATORY SYNCYTIAL VIRUS BY 2-5A ANT..:

Cramer, Hagen ; Okicki, James R. ; Kuang, Mei.
Nucleosides, Nucleotides & Nucleic Acids.  24 (2005)  5-7 - p. 497-501 , 2005
Link: https://doi.org/10.1081/..
 
?
5

Potent inhibition of respiratory syncytial virus by combina..:

Xu, Zan ; Kuang, Mei ; Okicki, James R...
Antiviral Research.  61 (2004)  3 - p. 195-206 , 2004
Link: https://doi.org/10.1016/..
 
?
6

The Use of Triisopropylsilyl-oxymethyl (TOM) in the Synthes..:

Cramer, Hagen ; Rhea, Rachele ; Okicki, Jim..
Nucleosides, Nucleotides and Nucleic Acids.  22 (2003)  5-8 - p. 1733-1736 , 2003
Link: https://doi.org/10.1081/..
 
?
7

Targeted Therapy of Respiratory Syncytial Virus in African ..:

Leaman, Douglas W. ; Longano, Frank J. ; Okicki, James R....
Virology.  292 (2002)  1 - p. 70-77 , 2002
Link: https://doi.org/10.1006/..
 
?
8

2-5A Antisense Directed against Telomerase RNA Produces Apo..:

Kushner, David M. ; Paranjape, Jayashree M. ; Bandyopadhyay, Bhaswati...
Gynecologic Oncology.  76 (2000)  2 - p. 183-192 , 2000
Link: https://doi.org/10.1006/..
 
?
9

Nucleotides LXIV[1]: Synthesis, Hybridization and Enzymatic..:

Cramer, Hagen ; Pfleiderer, Wolfgang
Nucleosides, Nucleotides and Nucleic Acids.  19 (2000)  10-12 - p. 1765-1777 , 2000
Link: https://doi.org/10.1080/..
 
?
10

Discrimination between ribonuclease H- and ribonuclease L-m..:

Cramer, Hagen ; Player, Mark R. ; Torrence, Paul F.
Bioorganic & Medicinal Chemistry Letters.  9 (1999)  7 - p. 1049-1054 , 1999
Link: https://doi.org/10.1016/..
 
?
11

Controlling Gene Expression with 2-5A Antisense:

Leaman, Douglas W. ; Cramer, Hagen
Methods.  18 (1999)  3 - p. 252-265 , 1999
Link: https://doi.org/10.1006/..
 
?
12

Using Fluorescence Resonance Energy Transfer (FRET) for Mea..:

Cramer, Hagen ; Geselowitz, Daniel A. ; Torrence, Paul F.
Nucleosides and Nucleotides.  18 (1999)  6-7 - p. 1523-1525 , 1999
Link: https://doi.org/10.1080/..
 
?
13

Nucleotides, Part LX, Synthesis and Characterization of New..:

Cramer, Hagen ; Pfleiderer, Wolfgang
Helvetica Chimica Acta.  82 (1999)  4 - p. 614-632 , 1999
Link: https://doi.org/10.1002/..
 
?
14

Methods for the Characterization of Phosphatase-Stabilized ..:

Player, Mark R. ; Xiao, Wei ; Cramer, Hagen.
Bioconjugate Chemistry.  9 (1998)  1 - p. 137-142 , 1998
Link: https://doi.org/10.1021/..
 
?
15

Synthesis of (2′,5′)-Oligoadenylate Antisense Chimeras Targ..:

Cramer, Hagen ; Terrence, Paul F.
Nucleosides and Nucleotides.  16 (1997)  7-9 - p. 1201-1204 , 1997
Link: https://doi.org/10.1080/..
 
1-15